col69 I agree. Where the making of submissions for approval resources (human and money) are limited then it makes sense to priorities those geo locations of most need provided they have a large market size. There are plenty of places that fit that category. The matrix of locations could include those places where the population has a propensity to not be immunized as people who refuse a vaccine may well see VIRALEZE as a sensible shield against infection and so buy it.
col69 I agree. Where the making of submissions for approval...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $45.99M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 12.0¢ | 10.5¢ | $114.6K | 998.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 171158 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 204 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |